|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 141 NORTHWEST POINT BLVD. |
Address2 | |
City | ELK GROVE VILLAGE |
State | IL |
Zip Code | 60007 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 1397-12
|
||||||||
|
6. House ID# 321820000
|
TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Kathryn Matthews, Washington Office Administrator |
Date | 07/20/2012 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
Farm Bill Food Safety
Competitive foods standards Antibiotics in animal Agriculture
Dietary Guidelines for young children
WIC
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristen |
Mizzi |
|
|
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Children's Hospital Graduate Medical Education appropriations
Prevention and Public Health Fund
FY 13 Labor-HHS Appropriations
Pediatric Subspecialty Loan Repayment Program appropriations
FY 2013 HHS/FDA Appropriations
FY 2012 HHS/FDA appropriations
Medicaid
Syringe exchange funding
Pediatric subspecialty loan repayment
Title VII health professions
National Childrens Study appropriations
Pediatric device consortia funding
Teen pregnancy prevention
Indian Health Service
CDC Lead
NIH/NICHD appropriations
Education (CHGME) appropriations
ACF
Foster Care Reform
CAPTA
Head Start
Child Care and Development Block Grant
Interior, Environment
Agriculture
FDA food safety
USDA food safety
Child nutrition
House budget
EMSC
Ryan White CARE Act
FEMA
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sonya |
Clay |
|
|
|
Kristen |
Mizzi |
|
|
|
Alison |
Perencevich |
|
|
|
Ielnaz |
Kashefipour |
|
|
|
Patrick |
Johnson |
|
|
|
James |
Baumberger |
|
|
|
Mark |
Del Monte |
|
|
|
Betsy |
Dunford |
|
|
|
Tamar |
Haro |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
Consumer Product Safety Improvement Act Implementation Button batteries
Lead in children's products
Crib bumpers
Safe Sleep
17. House(s) of Congress and Federal agencies Check if None
Consumer Product Safety Commission (CPSC), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristen |
Mizzi |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DIS
16. Specific lobbying issues
Pandemic and All-Hazards Preparedness Act Reauthorization
National Biodefense Science Board
National Preparedness Goal
FY 2012 Appropriations-Labor HHS
National Health Security Strategy biennial Implementation Plan
National Disaster Recovery Framework
Department of Homeland Security Reauthorization
FEMA
Stafford Act
17. House(s) of Congress and Federal agencies Check if None
Federal Emergency Management Agency (FEMA), Administration for Children & Families (ACF), Food & Drug Administration (FDA), Homeland Security - Dept of (DHS), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Betsy |
Dunford |
|
|
|
Tamar |
Haro |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Early Head Start
Head Start
School Health (restraint and seclusion legislation)
anti-bullying legislation
Race to the Top-Early Learning
Safe Schools Improvement Act
ESEA reauthorization
Early education
Child Care Development Block Grant
School Access to Emergency Epinephrine
17. House(s) of Congress and Federal agencies Check if None
Administration for Children & Families (ACF), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Patrick |
Johnson |
|
|
|
Kristen |
Mizzi |
|
|
|
Alison |
Perencevich |
|
|
|
James |
Baumberger |
|
|
|
Mark |
Del Monte |
|
|
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
Lead
Mercury
Clean Air Act
Global Climate Change
Antibiotic resistance
Food Safety
Chemicals regulation
Clean Air Act standards
Chemicals regulation
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), Agriculture - Dept of (USDA), White House Office, Centers For Disease Control & Prevention (CDC), Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristen |
Mizzi |
|
|
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Child Abuse Prevention Violence Against Women Act (VAWA)
Foster care support
Child Welfare
Protect Our Kids Act of 2011
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Administration for Children & Families (ACF),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristen |
Mizzi |
|
|
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Drug Shortages
TRICARE insurance
BPCA, PREA, Pediatric Medical Devices Safety and Improvement Act
School Access to Emergency Epinephrine Act
Affordable Care Act
Essential Health Benefits (ACA)
Health Information Technology
Medicaid
Prevention issues
Bright Futures
Public Health and Prevention Fund
Immunization
Preventive services
Bright Futures
Public Health and Prevention Fund
injury prevention
Access to safe and effective pediatric drugs and devices
Best Pharmaceuticals for Children Act (BPCA)
Pediatric Research Equity Act (PREA)
Pediatric Medical Devices Safety and Improvement Act
Medical Device User Fee Act (MDUFA)
Prescription Drug User Fee Act (PDUFA)
Medical device regulation
Sober Truth on Preventing (STOP) Underage Drinking Act reauthorization
FDA tobacco regulation
Family Smoking Prevention and Tobacco Control Act
Safety of cough and cold medicine for children
Smoking in public housing
Smoke-free movies
Tobacco in schools
Drug Shortages
Caffeine products
Emergency contraception
Contraception access
Psychotropic medication oversight
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Institutes of Health (NIH), Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), White House Office, Defense - Dept of (DOD), Housing & Urban Development - Dept of (HUD), White House Office, Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ielnaz |
Kashefipour |
|
|
|
Kristen |
Mizzi |
|
|
|
Patrick |
Johnson |
|
|
|
Alison |
Perencevich |
|
|
|
Mark |
Del Monte |
|
|
|
James |
Baumberger |
|
|
|
Robert |
Hall |
|
|
|
Tamar |
Haro |
|
|
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IND
16. Specific lobbying issues
Indian child welfare
Indian Health Service funding
Indian child health care coordination
Violence Against Women Act (VAWA) Reauthorization
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Indian Health Service,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristen |
Mizzi |
|
|
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Affordable Care Act
Medicaid
Essential Health Benefits
Access to preventive services
Bright Futures
Public Health and Prevention Fund
TRICARE for Kids legislation
Premium Stacking in Exchange coverage
Premium Tax Credits
Exchanges
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Labor - Dept of (DOL), Health & Human Services - Dept of (HHS), White House Office, Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alison |
Perencevich |
|
|
|
Ielnaz |
Kashefipour |
|
|
|
Robert |
Hall |
|
|
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicaid benefits
Medicaid Per-capita caps
Medicaid/CHIP blended rate
Medicaid expansion in ACA
Medicaid Benchmark plans
SGR
Health Information Technology
17. House(s) of Congress and Federal agencies Check if None
Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert |
Hall |
|
|
|
Ielnaz |
Kashefipour |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRA
16. Specific lobbying issues
Moving ahead for Progress in the 21st Century Act child safety restraints
Graduated driver's license EMSC
Child passenger safety
Backover Crash Prevention
17. House(s) of Congress and Federal agencies Check if None
Transportation - Dept of (DOT), Natl Highway Traffic Safety Administration (NHTSA), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristen |
Mizzi |
|
|
|
Betsy |
Dunford |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Medical Countermeasures for Children
Translational research center at NIH
National Children's Study
Medical Countermeasures for Children
17. House(s) of Congress and Federal agencies Check if None
Homeland Security - Dept of (DHS), Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tamar |
Haro |
|
|
|
James |
Baumberger |
|
|
|
Mark |
Del Monte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Subspecialty loan repayment Affordable Employer coverage in ACA
CHGME
Small Business Tax Credit in ACA
Employer mandate in ACA
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ielnaz |
Kashefipour |
|
|
|
Robert |
Hall |
|
|
|
Betsy |
Dunford |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Translational research center at NIH
National Children's Study
Inclusion of Children in Research
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James |
Baumberger |
|
|
|
Mark |
Del Monte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |